MENU
HGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Humanigen (HGEN) Ownership - Who owns Humanigen?

Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective... Show more

Profile

Industry
N/A
Address
830 Morris Turnpike, 4th Floor
Phone
+1 973 200-3100
Employees
6
Web
https://www.humanigen.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
22.77M
P/E Ratio
N/A
Total Cash
3.1M
Projected Growth
N/A
Total Debt
25.39M
Revenue
1.7M
Risk (Beta)
1.34
Dividend Yield
N/A
Total Cash/Share
0.03
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
830 Morris Turnpike, 4th Floor
Phone
+1 973 200-3100
Employees
6
Web
https://www.humanigen.com